Talk

Solving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions

In this interactive panel discussion, five industry experts share their experience on topics such as promising technologies and applications in the field, how CRISPR/Cas9 can be used alongside other methods to enhance drug development and the advances and challenges of cell models in drug discovery.
Solving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions
Kam Dhaliwal | SVP Alliance Management | bit.bio (Chair)
Solving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions
In this interactive panel discussion, five industry experts share their experience on topics such as promising technologies and applications in the field, how CRISPR/Cas9 can be used alongside other methods to enhance drug development and the advances and challenges of cell models in drug discovery.
Solving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions
Kam Dhaliwal | SVP Alliance Management | bit.bio (Chair)

Listen to experienced industry panellists engage in a thought-provoking discussion relating to new technologies within drug discovery.

2020

 

Panellists

Kam Dhaliwal | SVP Alliance Management | bit.bio (chair)

Steve Rees | Vice President Discovery Biology | AstraZeneca

Benedict Cross | Chief Technology Officer | PhoreMost Ltd

Tilmann Buerckstuemmer | Chief Scientific Officer | Aelian Biotechnology GmbH

Marijn Vlaming | Head of Biology | Beerse & Leiden | Charles River Laboratories

bit.bio panel discussion at ELRIG Drug Discovery Digital

Download resource

Related pages

News Read our latest updates and press coverage
Our platform Discover the cell identity coding platform behind our cells
Join us Explore the latest roles at bit.bio